There were 44 838 and 12 724 ALT tests in the full RA and IBD populations, respectively; 47 772 (RA) and 13 739 (IBD) WBC tests; and 95 162 (RA) and 26 673 (IBD) eGFR tests. This evidence concerns the gene GPT and rheumatoid arthritis.